*Emergent BioSolutions [EBS] received a $400 million contract from the Department of Health and Human Services (HHS) to provide 18.75 million doses of the anthrax vaccine BioThrax through Sept. 2010 for the strategic national stockpile. Contract terms also include an additional $34 million if the Food and Drug Administration approves the company's pending supplement to its biologics license application to extend the shelf life of BioThrax from three years to four years. On top of all that, HHS will provide…
Recommended
Trending
Congress Updates
Army Relooking At Its ‘Whole Aviation Transformation’ Plan, Acting Chief Tells Lawmakers
The Army is relooking at its “whole aviation transformation initiative,” the service’s acting chief of staff told lawmakers on Tuesday, to include its approach for future procurement of “enduring” platforms. […]
Lawmakers Request DoD Briefing On Army’s Planned Cuts To Aviation Procurement
A bipartisan group of House lawmakers has sent a letter asking the Pentagon for a briefing on the potential industrial base impacts as a result of the Army’s planned cuts […]
CENTCOM Looking To Lessons Learned From Use Of LUCAS Drones
U.S Central Command (CENTCOM) is looking to lessons learned from its use of Low-cost Unmanned Combat Attack System (LUCAS) drones by Phoenix-based SpektreWorks, according to CENTCOM head Adm. Brad Cooper. […]
Hegseth Says DoD Open To Reviewing Army’s Planned Cuts To Legacy Helicopter Procurement
Defense Secretary Pete Hegseth has told lawmakers the Pentagon is open to reviewing the Army’s planned procurement cuts to its legacy manned aviation fleet. Rep. Rosa DeLauro (D-Conn.), ranking member […]